Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2012

01-10-2012 | Article

Bacteremia with Streptococcus pneumoniae: sepsis and other risk factors for 30-day mortality—a hospital-based cohort study

Authors: J. S. Christensen, T. G. Jensen, H. J. Kolmos, C. Pedersen, A. Lassen

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2012

Login to get access

Abstract

We conducted a hospital-based cohort study among adult patients with first-time Streptococcus pneumoniae bacteremia (SPB) from 2000 through 2008. Patients were identified in a population-based bacteremia database and followed up for mortality through the Danish Civil Registration System (CRS). The aim of the study was to determine the focal diagnosis of SPB, the severity of sepsis at presentation, demographics and comorbidity characteristics of the patients, and to determine the 30-day mortality rate and factors related to mortality. We identified 481 patients, of which 238 were males. The mean age of the patients was 65 years. The focal diagnosis of the SPB was pneumonia in 381 (79 %) patients, followed in frequency by meningitis in 33 (7 %) patients. Of the 481 patients, 390 (81 %) had community-acquired SPB. Of these, 23 (6 %) did not have sepsis, 132 (34 %) had sepsis, 224 (57 %) had severe sepsis, and 11 (3 %) were in septic shock. Overall, the 30-day mortality was 16 %. Mortality increased with the severity of sepsis. There was no association between the focal diagnosis of SPB or the number of diagnoses and mortality. Nosocomial infection, male sex, increasing age, and increasing comorbidity were all associated with an increased 30-day mortality rate.
Literature
1.
go back to reference Konradsen HB, Kaltoft MS (2002) Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol 9:358–365PubMed Konradsen HB, Kaltoft MS (2002) Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol 9:358–365PubMed
2.
go back to reference Nielsen SV, Henrichsen J (1996) Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989–94. Epidemiol Infect 117:411–416PubMedCrossRef Nielsen SV, Henrichsen J (1996) Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989–94. Epidemiol Infect 117:411–416PubMedCrossRef
3.
go back to reference Kyaw MH, Clarke S, Jones IG, Campbell H (2002) Incidence of invasive pneumococcal disease in Scotland, 1988–99. Epidemiol Infect 128:139–147PubMed Kyaw MH, Clarke S, Jones IG, Campbell H (2002) Incidence of invasive pneumococcal disease in Scotland, 1988–99. Epidemiol Infect 128:139–147PubMed
4.
go back to reference Dahl MS, Trollfors B, Claesson BA, Brandberg LL, Rosengren A (2001) Invasive pneumococcal infections in Southwestern Sweden: a second follow-up period of 15 years. Scand J Infect Dis 33:667–672PubMedCrossRef Dahl MS, Trollfors B, Claesson BA, Brandberg LL, Rosengren A (2001) Invasive pneumococcal infections in Southwestern Sweden: a second follow-up period of 15 years. Scand J Infect Dis 33:667–672PubMedCrossRef
5.
go back to reference Kalin M, Örtqvist Å, Almela M, Aufwerber E, Dwyer R, Henriques B, Jorup C, Julander I, Marrie TJ, Mufson MA, Riquelme R, Thalme A, Torres A, Woodhead MA (2000) Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis 182:840–847PubMedCrossRef Kalin M, Örtqvist Å, Almela M, Aufwerber E, Dwyer R, Henriques B, Jorup C, Julander I, Marrie TJ, Mufson MA, Riquelme R, Thalme A, Torres A, Woodhead MA (2000) Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis 182:840–847PubMedCrossRef
6.
go back to reference Afessa B, Greaves WL, Frederick WR (1995) Pneumococcal bacteremia in adults: a 14-year experience in an inner-city university hospital. Clin Infect Dis 21:345–351PubMedCrossRef Afessa B, Greaves WL, Frederick WR (1995) Pneumococcal bacteremia in adults: a 14-year experience in an inner-city university hospital. Clin Infect Dis 21:345–351PubMedCrossRef
7.
go back to reference Mufson MA, Stanek RJ (1999) Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978–1997. Am J Med 107(1A):34S–43SPubMedCrossRef Mufson MA, Stanek RJ (1999) Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978–1997. Am J Med 107(1A):34S–43SPubMedCrossRef
8.
go back to reference Örtqvist Å, Kalin M, Julander I, Mufson MA (1993) Deaths in bacteremic pneumococcal pneumonia. A comparison of two populations—Huntington, WVa, and Stockholm, Sweden. Chest 103:710–716PubMedCrossRef Örtqvist Å, Kalin M, Julander I, Mufson MA (1993) Deaths in bacteremic pneumococcal pneumonia. A comparison of two populations—Huntington, WVa, and Stockholm, Sweden. Chest 103:710–716PubMedCrossRef
9.
go back to reference Watanakunakorn C, Greifenstein A, Stroh K, Jarjoura DG, Blend D, Cugino A, Ognibene AJ (1993) Pneumococcal bacteremia in three community teaching hospitals from 1980 to 1989. Chest 103:1152–1156PubMedCrossRef Watanakunakorn C, Greifenstein A, Stroh K, Jarjoura DG, Blend D, Cugino A, Ognibene AJ (1993) Pneumococcal bacteremia in three community teaching hospitals from 1980 to 1989. Chest 103:1152–1156PubMedCrossRef
10.
go back to reference Austrian R, Gold J (1964) Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 60:759–776PubMed Austrian R, Gold J (1964) Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 60:759–776PubMed
11.
go back to reference Harboe ZB, Thomsen RW, Riis A, Valentiner-Branth P, Christensen JJ, Lambertsen L, Krogfelt KA, Konradsen HB, Benfield TL (2009) Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 6:e1000081PubMedCrossRef Harboe ZB, Thomsen RW, Riis A, Valentiner-Branth P, Christensen JJ, Lambertsen L, Krogfelt KA, Konradsen HB, Benfield TL (2009) Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 6:e1000081PubMedCrossRef
12.
go back to reference Alanee SRJ, McGee L, Jackson D, Chiou CC, Feldman C, Morris AJ, Örtqvist A, Rello J, Luna CM, Baddour LM, Ip M, Yu VL, Klugman KP; International Pneumococcal Study Group (2007) Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis 45:46–51PubMedCrossRef Alanee SRJ, McGee L, Jackson D, Chiou CC, Feldman C, Morris AJ, Örtqvist A, Rello J, Luna CM, Baddour LM, Ip M, Yu VL, Klugman KP; International Pneumococcal Study Group (2007) Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis 45:46–51PubMedCrossRef
13.
go back to reference Plouffe JF, Breiman RF, Facklam RR (1996) Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group. JAMA 275:194–198PubMedCrossRef Plouffe JF, Breiman RF, Facklam RR (1996) Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group. JAMA 275:194–198PubMedCrossRef
14.
go back to reference Yu VL, Chiou CC, Feldman C, Ortqvist A, Rello J, Morris AJ, Baddour LM, Luna CM, Snydman DR, Ip M, Ko WC, Chedid MB, Andremont A, Klugman KP; International Pneumococcal Study Group (2003) An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 37:230–237PubMedCrossRef Yu VL, Chiou CC, Feldman C, Ortqvist A, Rello J, Morris AJ, Baddour LM, Luna CM, Snydman DR, Ip M, Ko WC, Chedid MB, Andremont A, Klugman KP; International Pneumococcal Study Group (2003) An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 37:230–237PubMedCrossRef
15.
go back to reference Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655PubMedCrossRef Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655PubMedCrossRef
17.
go back to reference Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 27:117–123CrossRef Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 27:117–123CrossRef
18.
go back to reference Shapiro N, Howell MD, Bates DW, Angus DC, Ngo L, Talmor D (2006) The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med 48:583–590PubMedCrossRef Shapiro N, Howell MD, Bates DW, Angus DC, Ngo L, Talmor D (2006) The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med 48:583–590PubMedCrossRef
19.
20.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef
21.
go back to reference Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309–392PubMedCrossRef Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309–392PubMedCrossRef
22.
go back to reference Bouza E, Pintado V, Rivera S, Blázquez R, Muñoz P, Cercenado E, Loza E, Rodríguez-Créixems M, Moreno S; Spanish Pneumococcal Infection Study Network (G03/103) (2005) Nosocomial bloodstream infections caused by Streptococcus pneumoniae. Clin Microbiol Infect 11:919–924PubMedCrossRef Bouza E, Pintado V, Rivera S, Blázquez R, Muñoz P, Cercenado E, Loza E, Rodríguez-Créixems M, Moreno S; Spanish Pneumococcal Infection Study Network (G03/103) (2005) Nosocomial bloodstream infections caused by Streptococcus pneumoniae. Clin Microbiol Infect 11:919–924PubMedCrossRef
23.
go back to reference Søgaard M, Nørgaard M, Dethlefsen C, Schønheyder HC (2011) Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis 52:61–69PubMedCrossRef Søgaard M, Nørgaard M, Dethlefsen C, Schønheyder HC (2011) Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis 52:61–69PubMedCrossRef
24.
go back to reference Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310PubMedCrossRef Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310PubMedCrossRef
25.
go back to reference Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Régnier B (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 274:968–974PubMedCrossRef Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Régnier B (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 274:968–974PubMedCrossRef
26.
go back to reference Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596PubMedCrossRef Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596PubMedCrossRef
27.
go back to reference Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW (2003) Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 31:670–675PubMedCrossRef Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW (2003) Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 31:670–675PubMedCrossRef
Metadata
Title
Bacteremia with Streptococcus pneumoniae: sepsis and other risk factors for 30-day mortality—a hospital-based cohort study
Authors
J. S. Christensen
T. G. Jensen
H. J. Kolmos
C. Pedersen
A. Lassen
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1619-5

Other articles of this Issue 10/2012

European Journal of Clinical Microbiology & Infectious Diseases 10/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine